Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds

被引:19
作者
Andersson, Sara B. E. [1 ]
Alvebratt, Caroline [1 ]
Bergstrom, Christel A. S. [1 ]
机构
[1] Uppsala Univ, Dept Pharm, POB 580, SE-75123 Uppsala, Sweden
关键词
apparent solubility; controlled suspensions; dissolution-limited drug absorption; intrinsic dissolution rate; particle size reduction; CLASSIFICATION-SYSTEM; DRUGS; BIOAVAILABILITY;
D O I
10.1007/s11095-017-2188-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose To develop a small-scale set-up to rapidly and accurately determine the intrinsic dissolution rate (IDR) and apparent solubility of poorly water-soluble compounds. Methods The IDR and apparent solubility (S-app) were measured in fasted state simulated intestinal fluid (FaSSIF) for six model compounds using wet-milled controlled suspensions (1.0% (w/w) PVP and 0.2% (w/w) SDS) and the mu DISS Profiler. Particle size distribution was measured using a Zetasizer and the total surface area was calculated making use of the density of the compound. Powder and disc dissolution were performed and compared to the IDR of the controlled suspensions. Results The IDR values obtained from the controlled suspensions were in excellent agreement with IDR from disc measurements. The method used low amount of compound (mu g-scale) and the experiments were completed within a few minutes. The IDR values ranged from 0.2-70.6 mu g/min/cm(2) and the IDR/S-app ratio ranged from 0.015 to 0.23. This ratio was used to indicate particle size sensitivity on intestinal concentrations reached for poorly water-soluble compounds. Conclusions The established method is a new, desirable tool that provides the means for rapid and highly accurate measurements of the IDR and apparent solubility in biorelevant dissolution media. The IDR/S-app is proposed as a measure of particle size sensitivity when significant solubilization may occur.
引用
收藏
页码:1805 / 1816
页数:12
相关论文
共 22 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs [J].
Andersson, Sara B. E. ;
Alvebratt, Caroline ;
Bevernage, Jan ;
Bonneau, Damien ;
Mathews, Claudia da Costa ;
Dattani, Rikesh ;
Edueng, Khadijah ;
He, Yan ;
Holm, Rene ;
Madsen, Cecilie ;
Mueller, Thomas ;
Muenster, Uwe ;
Mullertz, Anette ;
Ojala, Krista ;
Rades, Thomas ;
Sieger, Peter ;
Bergstrom, Christel A. S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) :2864-2872
[3]   Miniaturized rotating disk intrinsic dissolution rate measurement: Effects of buffer capacity in comparisons to traditional Wood's apparatus [J].
Avdeef, Alex ;
Tsinman, Oksana .
PHARMACEUTICAL RESEARCH, 2008, 25 (11) :2613-2627
[4]  
Benet LZ., 2006, B TECHNIQUE GATTEFOS, V99, P9
[5]   Is the full potential of the biopharmaceutics classification system reached? [J].
Bergstrom, Christel A. S. ;
Andersson, Sara B. E. ;
Fagerberg, Jonas H. ;
Ragnarsson, Gert ;
Lindahl, Anders .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 57 :224-231
[6]   The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development [J].
Butler, James M. ;
Dressman, Jennifer B. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (12) :4940-4954
[7]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[8]   Dissolution Rate and Apparent Solubility of Poorly Soluble Drugs in Biorelevant Dissolution Media [J].
Fagerberg, Jonas H. ;
Tsinman, Oksana ;
Sun, Na ;
Tsinman, Konstantin ;
Avdeef, Alex ;
Bergstrom, Christel A. S. .
MOLECULAR PHARMACEUTICS, 2010, 7 (05) :1419-1430
[9]  
Hoelgaard A, 1973, ARCH PHARM CHEMI SCI, V1, P1
[10]   Use of the biopharmaceutical classification system in early drug development [J].
Ku, M. Sherry .
AAPS JOURNAL, 2008, 10 (01) :208-212